GeneDx Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . GeneDx Holdings Corp
WGSWW Stock   0.04  0.0005  1.39%   
GeneDx Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing GeneDx Holdings' valuation are provided below:
Gross Profit
280.1 M
Profit Margin
0.0052
Revenue
402.2 M
Quarterly Revenue Growth
0.519
Revenue Per Share
14.199
There are over one hundred nineteen available fundamental trends for GeneDx Holdings Corp, which can be analyzed over time and compared to other ratios. All traders should should confirm GeneDx Holdings' regular fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Enterprise Value is likely to climb to about 2 B in 2026, whereas Market Cap is likely to drop slightly above 1.2 B in 2026.

GeneDx Holdings Total Revenue

243.91 Million

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 28.4 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 5.59, Dividend Yield of 0.0 or PTB Ratio of 9.21. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Build AI portfolio with GeneDx Stock
Check out the analysis of GeneDx Holdings Correlation against competitors.

GeneDx Holdings Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding32.5 M30.9 M11.2 M
Slightly volatile
Total Assets481.6 M482.3 M333.5 M
Slightly volatile
Short and Long Term Debt Total85.6 M133.6 M61.2 M
Slightly volatile
Other Current Liabilities43.1 M39.2 M45.1 M
Pretty Stable
Total Current Liabilities69.2 M49.3 M75.6 M
Very volatile
Total Stockholder Equity246.3 M282 M99.5 M
Slightly volatile
Property Plant And Equipment Net52.5 M52.7 M62.6 M
Pretty Stable
Current Deferred Revenue34.2 K36 K1.2 M
Slightly volatile
Accounts Payable6.8 M7.2 M24.5 M
Slightly volatile
Cash133 M76.7 M124.8 M
Pretty Stable
Non Current Assets Total206.5 M254.6 M127.9 M
Slightly volatile
Non Currrent Assets Other4.1 M3.9 M4.1 M
Slightly volatile
Long Term Debt31 M59.7 M24.8 M
Slightly volatile
Cash And Short Term Investments146.8 M127.1 M133.7 M
Slightly volatile
Net Receivables38 M43.3 M34 M
Slightly volatile
Liabilities And Stockholders Equity481.6 M482.3 M333.5 M
Slightly volatile
Non Current Liabilities Total101.9 M107.4 M152 M
Slightly volatile
Capital Lease Obligations53.5 M73.9 M36.1 M
Slightly volatile
Inventory14.6 M9.6 M21.5 M
Slightly volatile
Other Current Assets11 M7.7 M10.3 M
Slightly volatile
Total Liabilities171.1 M156.7 M227.7 M
Slightly volatile
Property Plant And Equipment Gross112 M127.6 M98.9 M
Slightly volatile
Short and Long Term Debt424.9 K447.3 K1.8 M
Pretty Stable
Total Current Assets200.1 M178.2 M198.2 M
Pretty Stable
Non Current Liabilities Other14.4 M27.1 M8.8 M
Slightly volatile
Net Working Capital130.9 M128.8 M122.6 M
Slightly volatile
Short Term Debt5.6 M3.8 M4.1 M
Slightly volatile
Common Stock1.7 K1.8 K19.6 K
Slightly volatile
Intangible Assets138.1 M142.7 M178.7 M
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Accumulated Other Comprehensive Income690.2 K954.5 K495.6 K
Slightly volatile

GeneDx Holdings Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.1 M2.9 M1.4 M
Slightly volatile
Depreciation And Amortization28.4 M25.2 M15.7 M
Slightly volatile
Interest Expense2.7 M3.5 M1.7 M
Slightly volatile
Selling General Administrative144.3 M116.3 M77.2 M
Slightly volatile
Selling And Marketing Expenses85.4 M77.5 M57.8 M
Slightly volatile
Total Revenue243.9 M351.3 M217.1 M
Slightly volatile
Other Operating Expenses535.4 M378 M345.5 M
Slightly volatile
Research Development53.7 M41.1 M47.8 M
Slightly volatile
Cost Of Revenue133.7 M99.9 M132.7 M
Slightly volatile
Total Operating Expenses351.6 M250.3 M208.1 M
Slightly volatile
Reconciled Depreciation28.4 M25.2 M15.7 M
Slightly volatile

GeneDx Holdings Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow160.4 M115.8 M68.3 M
Slightly volatile
Other Cashflows From Financing Activities761.8 K801.9 K99.1 M
Slightly volatile
Depreciation28.8 M25.2 M15.8 M
Slightly volatile
Capital Expenditures4.7 M4.9 M14.3 M
Slightly volatile
Total Cash From Financing Activities37.8 M39.7 M153.4 M
Pretty Stable
End Period Cash Flow127.9 M77.6 M129.4 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.597.787.4887
Slightly volatile
PTB Ratio9.219.69304
Slightly volatile
Days Sales Outstanding62.2651.7162.0644
Slightly volatile
Book Value Per Share9.9610.4911.2243
Slightly volatile
Capex To Depreciation0.270.291.7066
Slightly volatile
PB Ratio9.219.69304
Slightly volatile
EV To Sales4.197.98.3421
Slightly volatile
Inventory Turnover9.09.388.5206
Slightly volatile
Days Of Inventory On Hand41.3440.2546.4257
Slightly volatile
Payables Turnover6.7712.577.4833
Slightly volatile
Sales General And Administrative To Revenue0.480.30.3369
Slightly volatile
Research And Ddevelopement To Revenue0.340.170.235
Slightly volatile
Capex To Revenue0.01960.02070.0713
Slightly volatile
Cash Per Share5.746.0421.7358
Very volatile
Days Payables Outstanding55.1230.0652.4972
Slightly volatile
Income Quality0.530.490.6258
Very volatile
Intangibles To Total Assets0.30.340.3459
Pretty Stable
Current Ratio2.463.252.6322
Slightly volatile
Tangible Book Value Per Share3.523.718.6095
Pretty Stable
Receivables Turnover5.327.315.9606
Slightly volatile
Shareholders Equity Per Share9.9610.4911.2243
Slightly volatile
Debt To Equity0.520.546.5224
Slightly volatile
Capex Per Share0.220.232.458
Slightly volatile
Revenue Per Share12.4113.0630.1999
Slightly volatile
Interest Debt Per Share7.985.17.6812
Slightly volatile
Debt To Assets0.150.250.1797
Pretty Stable
Operating Cycle10491.96108
Slightly volatile
Price Book Value Ratio9.219.69304
Slightly volatile
Days Of Payables Outstanding55.1230.0652.4972
Slightly volatile
Ebt Per Ebit2.142.041.155
Slightly volatile
Effective Tax Rate0.00710.00750.0643
Slightly volatile
Company Equity Multiplier1.871.9737.7523
Slightly volatile
Long Term Debt To Capitalization0.280.20.5781
Slightly volatile
Total Debt To Capitalization0.420.370.6914
Slightly volatile
Debt Equity Ratio0.520.546.5224
Slightly volatile
Quick Ratio2.273.082.3458
Slightly volatile
Net Income Per E B T0.780.890.9172
Pretty Stable
Cash Ratio2.121.791.6625
Slightly volatile
Cash Conversion Cycle35.2648.4454.4236
Slightly volatile
Days Of Inventory Outstanding41.3440.2546.4257
Slightly volatile
Days Of Sales Outstanding62.2651.7162.0644
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.391.371.5726
Slightly volatile
Price To Book Ratio9.219.69304
Slightly volatile
Fixed Asset Turnover2.824.73.1515
Slightly volatile
Debt Ratio0.150.250.1797
Pretty Stable
Price Sales Ratio5.597.787.4887
Slightly volatile
Asset Turnover0.440.660.6449
Slightly volatile
Price Fair Value9.219.69304
Slightly volatile

GeneDx Holdings Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.2 B2.4 B1.6 B
Slightly volatile
Enterprise Value2 B1.9 B1.6 B
Slightly volatile

GeneDx Fundamental Market Drivers

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue36 K34.2 K
Total Revenue351.3 M243.9 M
Cost Of Revenue99.9 M133.7 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.30  0.48 
Research And Ddevelopement To Revenue 0.17  0.34 
Capex To Revenue 0.02  0.02 
Revenue Per Share 13.06  12.41 
Ebit Per Revenue(0.07)(0.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY